Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study
Authors:
- 27 September 2021
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 28 (1) , 130-134
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Bell's palsy and SARS-CoV-2 vaccinesThe Lancet Infectious Diseases, 2021
- Herpes zoster following inactivated COVID‐19 vaccine: A coexistence or coincidence?Journal of Cosmetic Dermatology, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associationsBrain, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesNew England Journal of Medicine, 2020
- Bell's Palsy: Clinical Analysis of 372 Cases and Review of Related LiteratureEuropean Neurology, 2017
- Analysis of matched case-control studiesBMJ, 2016
- Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-AnalysisNeuroepidemiology, 2011
- Epidemiology of Bell’s palsy in an Italian Health District: incidence and case-control study2010